Interface Biologics
www.interfacebiologics.comInterface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Read more
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI’s primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.
Read more
Country
City (Headquarters)
Toronto
Industry
Employees
11-50
Founded
2001
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President , Finance
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Member , Board of Directors
Email ****** @****.comPhone (***) ****-****Research Engineer Ii
Email ****** @****.comPhone (***) ****-****
Technologies
(12)
We'll help you understand if Lusha can solve your business needs.
